Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H25NO2 |
Molecular Weight | 299.4073 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CC#CCCC(=O)C(O)(C1CCC1)C2=CC=CC=C2
InChI
InChIKey=BCOZTAXOTDBLEA-UHFFFAOYSA-N
InChI=1S/C19H25NO2/c1-20(2)15-8-4-7-14-18(21)19(22,17-12-9-13-17)16-10-5-3-6-11-16/h3,5-6,10-11,17,22H,7,9,12-15H2,1-2H3
Molecular Formula | C19H25NO2 |
Molecular Weight | 299.4073 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1920357
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1920357
MDL 201012 is a muscarinic M3 receptor antagonist.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL245 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1920357 |
4.9 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Analogues of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds. | 1991 Oct |
|
Determination of MDL 201,012 at femtomole/millilitre levels in human plasma by liquid chromatography with electrochemical detection. | 1992 Nov-Dec |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1286288
In acute dose tolerance studies MDL 201012 was administered to humans as an oral solution in a dose of 4 mg.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1920357
Antimuscarinic activity was measured using strips of guinea pig bladder tetrusor muscle. Isometric contractions were recorded as a response for agonist stimulation. Antimuscarinic studies were conducted by constructing concentration-response curves to carbachol in the absence and presence of several concentrations of antagonist. MDL 201012 inhibits carbachol-induced contraction of bladder strips with Ki of 4.9 nM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 13:56:23 GMT 2023
by
admin
on
Sat Dec 16 13:56:23 GMT 2023
|
Record UNII |
8UR0ZWJ83I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
131987
Created by
admin on Sat Dec 16 13:56:23 GMT 2023 , Edited by admin on Sat Dec 16 13:56:23 GMT 2023
|
PRIMARY | |||
|
136722-45-7
Created by
admin on Sat Dec 16 13:56:23 GMT 2023 , Edited by admin on Sat Dec 16 13:56:23 GMT 2023
|
PRIMARY | |||
|
8UR0ZWJ83I
Created by
admin on Sat Dec 16 13:56:23 GMT 2023 , Edited by admin on Sat Dec 16 13:56:23 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |